Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (592)	2/18/1999 11:13:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

market cap to book ratio. this thread is devoted to good-science companies with a low ratio. >> Any interest in an options thread featuring an FDA calander for unusually important upcoming decisions to play options? << at least two S.I. biofreaks are interested big-time, John Dwyer and Peter Suzman. It would also be a cinch to hook John Metcalf on that one. In particular, John Dwyer was working on a formal model, predicting stuff around FDA pivotal stuff. I wouldn't participate much, but I might try to abscond with the take-homes. If you're asking if we'd be interested in seeing your observations (and discussions relating to them), I'm certain that the answer is a resounding yes. Other threads that would welcome such discussion would be the VDXX or BVF threads. I wouldn't count on a dime from myo. Good stuff. One comment.... there have been lots of bad bets placed on biotech, including many bad ones. But we will never suffer from having noted them. Thanks.